Home
About
Overview
Sharing Data
ORCID
Help
History (21)
Minimal Change Disease as a Secondary and Reversible Event of a Renal Transplant Case with Systemic Lupus Erythematosus.
Recurrent Complement-Mediated Thrombotic Microangiopathy in a Patient with Systemic Lupus Erythematosus: A Clinical Pathology Conference Held by the Division of Rheumatology at Hospital for Special Surgery.
Thompson, Amber
An Innovative Simulation-based Community-engaged Intervention for Training Research Assistants in Culturally Appropriate Informed Consent.
Anti-interferon alpha treatment in SLE.
See All 21 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Anti-interferon alpha treatment in SLE.
Kirou KA, Gkrouzman E. Anti-interferon alpha treatment in SLE. Clin Immunol. 2013 Sep; 148(3):303-12.
View in:
PubMed
subject areas
Animals
Dendritic Cells
Genetic Predisposition to Disease
Humans
Interferon-alpha
Lupus Erythematosus, Systemic
Receptor, Interferon alpha-beta
Signal Transduction
authors with profiles
Elena Gkrouzman MD, MS, RhMSUS